Markers for the central serotonin system correlate to verbal ability and paralinguistic social voice processing in autism spectrum disorder
Markers for the central serotonin system correlate to verbal ability and paralinguistic social voice processing in autism spectrum disorder
复制标题
中枢血清素系统的标记与自闭症谱系障碍的言语能力和副语言社交声音处理相关
DOI:
10.1038/s41598-020-71254-w
复制
发表时间:
2020
影响因子:
4.6
通讯作者:
Minabe Yoshio
中科院分区:
文献类型:
--
作者:
Yoshimura Yuko;Kikuchi Mitsuru;Saito Daisuke N.;Hirosawa Tetsu;Takahashi Tetsuya;Munesue Toshio;Kosaka Hirotaka;Naito Nobushige;Ouchi Yasuomi;Minabe Yoshio
Impairment in verbal communication abilities has been reported in autism spectrum disorder (ASD). Dysfunction of the serotonergic system has also been reported in ASD. However, it is still unknown how the brain serotonergic system relates to impairment in verbal communication abilities in individuals with ASD. In the present study, we investigated the correlation between brain serotonergic condition and brain sensitivity to paralinguistic stimuli (i.e., amplitude in the human voice prosodic change-evoked mismatch field) measured by magnetoencephalography (MEG) or verbal ability in 10 adults with ASD. To estimate the brain serotonergic condition, we measured the serotonin transporter nondisplaceable binding potential cerebrum-wide using positron emission tomography with [11C]N,N-dimethyl-2-(2-amino-4-cyanophenylthio)benzylamine ([11C] DASB). The results demonstrated a significant positive correlation between brain activity to paralinguistic stimuli and brain serotonin transporter binding potential in the left lingual gyrus, left fusiform gyrus and left calcarine cortex. In addition, there were significant positive correlations between verbal ability and serotonergic condition in the right anterior insula, right putamen and right central operculum. These results suggested that the occipital cortex is implicated in recognition of the prosodic change in ASD, whereas the right insula-involved serotonergic system is important in nurturing verbal function in ASD.Trial registration: UMIN000011077.